baber/WOPTO huggingface dataset:
Patent CS-209934-B2 (CS)
Title: Means for regulation of the plants growth and method of making the active substances
Inventor: AHLE JAMES L
IPC: C07D295/192
Filed: 1979-09-11
Abstract: 1-Benzoyl-3-thiosemicarbazides of formula I: <CHEM>  wherein  R is   -@-R<1> or   -@@Q;  R<1> is -OH, -NR min R sec , C1-C4 alkyl or hydrogen;  Q is hydrogen, C1-C4 alkyl or C3-C6 cycloalkyl; each of R min  and R sec  independently is hydrogen, C1-C10 alkyl, C3-C7 alkoxyalkyl or alkoxyalkoxyalkyl, C3-C6 cycloalkyl, phenyl C1-C2 alkyl where the phenyl group is optionally substituted by halo or C1-C4 alkoxy; or R min  and R sec  taken together with the nitrogen atom to which they are attached form a heterocyclic ring containing from 5 to 7 ring atoms; each R<2> independently is halogen, C1-C4 alkyl, C1-C4 alkoxy, nitro or trifluoromethyl;  m is 0, 1 or 2; R<3> is hydrogen, C1-C4 alkyl, C3-C4 alkyl, C3-C4 alkenyl containing no  alpha , beta  unsaturation, C1-C4 hydroxyalkyl, phenyl or benzyl;  R<4> is hydrogen or C1-C4 alkyl; Ar is naphthyl, anthranyl, phenanthryl or a group having one of the following formulae; <CHEM> each R<5> independently is C1-C4 alkyl, halo, nitro, C1-C4 alkoxy or C1-C4 alkylthio, provided that both ortho positions are not substituted by alkyl; R<6> is C1-C4 carbalkoxy, phenoxy, benzyloxy, phenyl, amino, C1-C4 alkylamino or di (C1-C4) alkylamino; n is 0, 1, 2 or 3;  q is 0 or 1; the sum of n plus q does not exceed 3; and p is 0 or 1; and agriculturally-acceptable salts and esdters thereof, are useful in plant growth regulation. The preparation of these novel compounds is described.
Patent CS-199650-B2 (CS)
Title: Continuous method for the selective absorption of hydrogen sulphide from dosed gas
Inventor: BUTWELL KENNETH F
IPC: B01D53/52
Filed: 1976-10-29
Abstract: PROCESS FOR ACID GAS REMOVAL A continuous process for the selective absorption of hydrogen sulfide from a feed gas comprising an acid gas mixture of carbon dioxide and hydrogen sulfide is provided which comprises counter-currently contacting the feed gas with an aqueous alkanolamine solution in an absorption zone having from two to ten separate stages, contacting the feed gas in each stage with lean aqueous alkanolamine solution and withdrawing rich aqueous alkanolamine solution from the bottom of esch stage, in each stage maximizing the equilibrium approach between the hydrogen sulfide in the gas and liquid phases and minimizing the equilibrium approach between the carbon dioxide in the gas and liquid phases, and maintaining the rich solution loading in each stage within the range from about O.l to about 0.3 mole of acid gas per mole of alkanolamine.  The absorption zone is operated in combination with a stripping zone to which rich aqueous alkanolamine solution is passed and in which lean solution is generated.  The particular multi-stagP ~bsorption process of the invention allows for the recovery as stripping zone overhead of gaseous product in which the combined molar ratio of carbon dioxide to hydrogen sulfide is no greater than about 6. S P E C I F I C A T I O N
Patent JP-H0226581-B2 (JP)
IPC: B64C27/46
Filed: 1982-01-08
Abstract: The invention relates to a laminate composed of two, three, four or more aluminum-containing metal sheets. The metal sheets, which may for instance be of an aluminum alloy, are bonded together by means of adhesive layers. In the adhesive layers, which are of a thermohardening material, there are embedded poly-paraphenylene terephthalamide threads. These threads are provided in the form of yarns made up of endless filaments and lie in a practically straight line in the adhesive which substantially consists of a thermohardening material. The adhesive layers contain the threads in an amount of 20 to 80% by weight.
Patent JP-H0466314-B2 (JP)
IPC: C12Q1/28
Filed: 1987-01-09
Abstract: A stable test device for the determination of a peroxidatively active substance comprising a carrier containing 1,4-diisopropylbenzene dihydroperoxide and a benzidine indicator in a molar ratio of from 0.9 to 3.0. The composition can be incorporated with a carrier matrix with a ferric chelate to provide ascorbate resistance, important in a urine test for occult blood. The test device is stable under storage and heat stress and can be used to prepare a multitest strip containing a glucose test based on a peroxidase/potassium iodide indicator system.
Patent AU-777151-B2 (AU)
Title: Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
Inventor: BOULIKAS TENI
IPC: A61K33/243
Filed: 2000-10-27
Granted: 2004-10-07
Abstract: A method for encapsulating cisplatin and other positively-charged drugs into liposomes having a different lipid composition between their inner and outer membrane bilayers is disclosed. The liposomes are able to reach primary tumors and their metastases after intravenous injection to animals and humans. The encapsulated cisplatin has a high therapeutic efficacy in eradicating a variety of solid human tumors including but not limited to breast carcinoma and prostate carcinoma. Combination of the encapsulated cisplatin with encapsulated doxorubicin or with other antineoplastic drugs are claimed to be of therapeutic value. Also of therapeutic value in cancer eradication are claimed to be combinations of encapsulated cisplatin with a number of anticancer genes including but not limited to p53, IL-2, IL-12, angiostatin, and oncostatin encapsulated into liposomes as well as combinations of encapsulated cisplatin with HSV-tk plus encapsulated ganciclovir.
Patent AU-657730-B2 (AU)
Title: Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
Inventor: GLUCK REINHARD
IPC: A61K47/48
Filed: 1992-01-17
Granted: 1995-03-23
Abstract: The phospholipid bi-layer vesicle contains at least one pharmaceutically active drug and comprises cell-specific markers on the membrane which have at least 90 % biological activity when measured according to Luescher & Glueck, Antiviral Research 14, 39-50. In the membrane, the cholesterol content is preferably less than 2% by weight, the detergent content preferably less than 1 ppb. The vesicle diameter preferably is about 80 nm. The phospholipid in the membrane may comprise 70 to 95 % by weight of phosphatidylcholine and preferably 10 to 20 % by weight of phosphatidylethanolamine; preferably 6 to 8 % by weight of a crosslinker, preferably of a sulfosuccinimidyl derivate, and at least one cell-specific fusion peptide are linked to the membrane. The vesicles are used for the preparation of pharmaceuticals against AIDS and carcinomas. The process for the preparation of phospholipid bi-layer vesicles comprises hemagglutinin as a cell-specific marker with at least one fusion peptide. The hemagglutinin is separated from a virus strain by means of a non-ionic detergent, preferably octaethylene glycol monododecyl ether. It is removed by repeatedly treating the solution with altogether about 1.5 g polystyrene beaded microcarriers per 100 mg detergent.
Patent AU-690627-B2 (AU)
Title: Recording apparatus, recording head and substrate therefor
Inventor: ISHINAGA HIROYUKI
IPC: B41J2/35
Filed: 1995-03-09
Granted: 1998-04-30
Abstract: The invention relates to a recording head and apparatus as well as to a substrate usable for the recording head. The substrate comprises electrical contacts for external electrical connection in order to receive image signals used for driving recording elements. A logic circuit converts the image signals which are serially supplied to the electrical contacts into parallel signals to be applied to the recording elements via electrical leads. The electrical contacts, the recording elements, the logic circuit, and selectors for selectively driving the recording elements are built in the substrate. The selectors are disposed in a one-to-one relation with the recording elements, corresponding to the interval of the recording elements. <IMAGE>
Patent AU-605580-B2 (AU)
Title: Aerosolization of protein therapeutic agent
Inventor: ROOSDORP NICOLAAS J
IPC: A61K38/00
Filed: 1988-04-29
Granted: 1991-01-17
Abstract: Aerosolization of therapeutic proteins is demonstrated using recombinant  alpha 1-antitrypsin for treatment of emphysema as paradigmatic.
Patent AU-696186-B2 (AU)
Title: Bacterial receptor structures
Inventor: NILSSON BJORN
IPC: C07K14/31
Filed: 1995-01-16
Granted: 1998-09-03
Abstract: Novel proteins obtainable by mutagenesis of surface-exposed amino acids of domains of natural bacterial receptors, said proteins being obtained without substantial loss of basic structure and stability of said natural bacterial receptors; proteins which have been selected from a protein library embodying a repertoire of said novel proteins; and methods for the manufacture of artificial bacterial receptor structures.
Patent AU-718497-B2 (AU)
Title: Locator method and apparatus
Inventor: LIFSHEY ARTHUR L
IPC: A61B6/12
Filed: 1995-03-02
Granted: 2000-04-13
Abstract: The invention relates to methods and apparatus for locating an internal injury. The apparatus includes a marker that is temporarily positionable at an external location adjacent the internal injury. The marker is formed of a material that is visible on an X-ray, magnetic resonance image, ultrasonic image, or other device for imaging the internal injury. The method includes the steps of positioning a marker at an external location adjacent an internal injury, simultaneously visualizing the marker and the internal injury, and marking an approximate external location corresponding to the internal injury. Where X-rays are used for simultaneously visualizing the marker and the internal injury, the X-ray is used to map the approximate external location corresponding to the internal injury.
Patent AU-668352-B2 (AU)
Title: Suppression of thromboxane levels by percutaneous administration of aspirin
Inventor: KEIMOWITZ RUDOLPH M
IPC: A61K47/10
Filed: 1992-04-02
Granted: 1996-05-02
Abstract: A method is disclosed for inducing thromboxane suppression in a mammalian subject by percutaneously administering a pharmaceutical composition containing aspirin. Articles useful for practicing the therapeutic methods of the invention are also disclosed.
Patent AU-610212-B2 (AU)
Title: Simple memory mechanism comprising a mechanical jack for tilting over control on the front of a vehicle seat
Inventor: PIPON YVES
IPC: B60N2/90
Filed: 1988-08-01
Granted: 1991-05-16
Abstract: Each front seat has under the base plate in its median longitudinal axis a rack connector rod and a mechanical bolt, this rack connector rod cooperating with a box joined to the floor of the vehicle via a framing and a brace, this box containing a blockable motor device. The entire afore-mentioned unit cooperates with two parallel arms first of all joined to the rear part of the seat and secondly joined to the floor of the vehicle via a spindle containing a memory constituted by a ring with a notch and the nose of the lever.
Patent AU-613412-B2 (AU)
Title: Process for the production of nitriles and anhydrides
Inventor: RAMACHANDRAN RAMAKRISHNAN
IPC: C07C51/215
Filed: 1988-10-14
Granted: 1991-08-01
Abstract: An improved process is provided for the production of anhydrides and nitriles from hydrocarbons by reaction with an oxygen-containing gas comprising oxygen, air or a gas enriched in oxygen relative to air and ammonia where a nitrile is desired, in the presence of a suitable catalyst. In the process, a selective separator provides recycle of a substantial portion of the unreacted hydrocarbon as well as for a controlled amount of a gaseous flame suppressor in the system. The gaseous flame suppressor comprises a substantially unreactive hydrocarbon containing 1 to 5 carbon atoms, carbon dioxide and nitrogen when present in the feed to the ammoxidation/oxidation reactor. The use of air or oxygen-enriched air in the feed to the ammoxidation/oxidation reactor is particularly advantageous from an economic view in combination with a pressure swing adsorption unit as the selective separator. The process is characterized by high selectivity to the formation of the product.
Patent AU-649164-B2 (AU)
Title: New(benzocycloalkyl)alkylamines, a process for their preparation and pharmaceutical compositions containing them
Inventor: PEGLION JEAN-LOUIS
IPC: C07D491/056
Filed: 1992-09-24
Granted: 1994-05-12
Abstract: Compounds of formula (I): 
<IMAGE>
 in which p and q, which are identical or different, represent 0, 1 or 2 provided that the sum p + q is equal to 1 or 2. 
<??>These compounds are useful in the treatment of cardiovascular ailments.
Patent AU-702352-B2 (AU)
Title: Asbestos-free gaskets and the like containing blends of organic fibrous and particulate components
Inventor: KAMINSKI STANLEY SIGMUND
IPC: C08J5/04
Filed: 1995-08-03
Granted: 1999-02-18
Abstract: A method for making a dry blend for use in the preparation of a friction material, a dry blend per se and dry friction materials is disclosed wherein the components thereof include a) fibrillated, organic, synthetic polymer, b) organic, synthetic polymer staple and c) organic, synthetic soluble polymer particles.
Patent AU-692574-B2 (AU)
Title: Lubricating oil production with vi-selective catalyst
Inventor: ZIEMER JAMES N
IPC: B01J29/16
Filed: 1995-06-20
Granted: 1998-06-11
Abstract: A process is provided for producing a high quality lubricating oil base stock with a catalyst having a high viscosity index selectivity and low fouling rate. The catalyst contains a low amount of zeolite, and has a pore size distribution characterized by a significant amount of large pores.
Patent AU-735500-B2 (AU)
Title: Device for the production of a dental working model for preparation of a prosthetic work
Inventor: BROWNE LAURENCE STEPHEN
IPC: A61C13/34
Filed: 1997-06-04
Granted: 2001-07-12
Abstract: PCT No. PCT/GB97/01508 Sec. 371 Date Dec. 3, 1998 Sec. 102(e) Date Dec. 3, 1998 PCT Filed Jun. 4, 1997 PCT Pub. No. WO97/46171 PCT Pub. Date Dec. 11, 1997A device for the production of a dental working model for preparation of a prosthetic work comprises a body member having a blind arcuated cavity bounded by facing inner and outer cavity walls, for receiving semi-liquid model material. The blind end of the arcuate cavity is closed by a sacrificial membrane which is integral with the body member. The membrane is of sufficient thickness to contain the semi-liquid model material within the arcuate cavity and of sufficient thinness to be easily removed, for example, by grinding.
Patent AU-610698-B2 (AU)
Title: Surface winder and method
Inventor: HERTEL JAMES E
IPC: B65H18/16
Filed: 1989-02-27
Granted: 1991-05-23
Abstract: There is disclosed a surface winder which in a preferred embodiment includes a stationary upper winding roll (23), a lower movable winding roll (28) and a rider roll (25) which form a three roll cradle, the lower winding roll (28) being reciprocated to control the position of a partially wound core (C) until the rider roll ((25) returns to cradle position after permitting passage of a previously wound log (L) and in which a compensator roll (51) is provided to control web (W) slack after cutoff and transfer.
Patent AU-710713-B2 (AU)
Title: Antigenic peptides derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection
Inventor: LANGEDIJK JOHANNES PETRUS MARI
IPC: A61K39/00
Filed: 1995-08-22
Granted: 1999-09-30
Abstract: PCT No. PCT/NL95/00279 Sec. 371 Date Feb. 25, 1997 Sec. 102(e) Date Feb. 25, 1997 PCT Filed Aug. 22, 1995 PCT Pub. No. WO96/06112 PCT Pub. Date Feb. 29, 1996Antigenic substance or precursor thereof comprising a peptide part derived from an amino acid sequence located between two mucin-like regions of a protein G of a respiratory syncytial virus (RSV). Said andgenic substance or precursor thereof allows to discriminate between, or identify, different types or subtypes of respiratory syncytial viruses, or antibodies against them. In preferred embodiments, the peptide part is derived from protein G of bovine respiratory syncytial virus, human respiratory syncytial virus A, human respiratory syncytial virus B, or ovine respiratory syncytial virus. Use of the antigenic substance or precursor thereof (in vaccines) for prophylaxis of RSV infections, in assays and testkits for detecting or identifying (antibodies against) RSV types or subtypes, and in methods for obtaining antibodies against RSV types or subtypes. Use of such antibodies in assays and testkits for detecting or identifying RSV types or subtypes.
Patent AU-745287-B2 (AU)
Title: Encapsulated lithium electrodes having glass protective layers and method for their preparation
Inventor: VISCO STEVE J
IPC: H01M10/052
Filed: 1999-03-29
Granted: 2002-03-21
Abstract: A method for fabricating an active metal electrode involves depositing lithium or other active metal electrode on a protective layer. The protective layer is a glassy or amorphous material that conducts ions of the active metal. It may be deposited on a releasable web carrier or other substrate such as polymer electrolyte layer. Lithium is then deposited on the protective layer. Finally, a current collector is attached to the lithium.
Patent AU-614366-B2 (AU)
Title: A machine for laterally shifting a track consisting of rails and sleepers
Inventor: THEURER JOSEF
IPC: E01B33/00
Filed: 1989-05-17
Granted: 1991-08-29
Abstract: Machine (1) for laterally shifting a railroad comprising rails (2) and transverse sleepers (3), having a machine frame (5) mounted on running gear (4). Provided on the machine frame are a vertically and laterally adjustable railroad lifting and shifting unit (13) having rolling tools, an apparatus (16) for aligning individual skewed sleepers (3) in the plane of the railroad, which is provided with an aligning tool  and is adjustable in the longitudinal direction of the railroad and vertically, and at least one clamping unit (22) which is vertically adjustable via a drive (24) and has attachable and vibratable clamping tools. The sleeper alignment apparatus (16), which is adjustable in the longitudinal direction of the railroad, forms, together with the railroad lifting and shifting unit (13), a combined compact working unit (17) with a common unit supporting frame (18). The latter is connected in an articulated manner to the machine frame (5) via hydraulic cylinder/piston drives (11, 12) for vertical and lateral adjustment. 
<IMAGE>
Patent AU-683778-B2 (AU)
Title: Wind amplified rotor platform systems
Inventor: WEISBRICH L ALFRED
IPC: F03D11/04
Filed: 1995-09-21
Granted: 1997-11-20
Abstract: An energy conversion device which comprises a stacked array of alternating yawable and fixed toroidal modules about a central core structure. The yawable toroids have typically four impact impellers mounted in their peripheral flow regions for the purpose of capturing flow energy. The fixed toroids are mounted to complement and further enhance fluid flow impact impeller energy capture and to provide housing means for a variety of matter both associated and unassociated with the energy system. The stacked array of a toroid with impellers, designated a Toroidal Rotor Amplifier Platform (TRAP TM ), and a toroid without impellers, designated a Toroidal Wind Frame (TWF TM ), is referred to in aggregate, when used for wind energy conversion, as a Wind Amplified Rotor Platforms (WARP TM ) system. Under wind energy conversion use, a WARP TM  system may be used also to both generate electric power and serve as a power line transmission support tower, and/or as a telecommunications or surveillance tower, housing within toroids related structural, transmitting and receiving equipment.
Patent AU-579356-B2 (AU)
Title: Signal transducing head moving apparatus
Inventor: TSUKAHARA NOBUHIKO
IPC: G11B5/55
Filed: 1985-03-28
Granted: 1988-11-24
Abstract: A signal transducing head moving apparatus using a stepping motor which comprises a reversible stepping motor (20) for moving a head and a motor drive control means (30, 40) for driving the stepping motor (20) in alternate forward and reverse directions through switching of excitation phases of the motor (20) after the motor (20) has been driven in one direction, thereby eliminating errors of the step position of the stepping motor (20) due to a hysteresis characteristic thereof. The head thus can be stopped at the same position irrespective of whether it is accessed in the forward or reverse direction.
Patent AU-686482-B2 (AU)
Title: Elastic flooring elements
Inventor: KUNG PETER
IPC: E01C5/20
Filed: 1995-12-15
Granted: 1998-02-05
Abstract: The plastics element has male coupling members (9) which project from the outer frame (1) as elongated bars parallel to the plane of the element. Each female coupling element (13) lying within the outer frame has two spring-elastic catches (14,15) which grip behind the bar (9). The elongated bar has a stop (10) for the two catches. The stop is made as a plate which protrudes over the face side of the bar.
Patent AU-660092-B2 (AU)
Title: Antioxidant compositions
Inventor: CLOUGHLEY JOHN BODEN
IPC: A23L3/3544
Filed: 1993-06-23
Granted: 1995-06-08
Abstract: Method of stabilising polyunsaturates by adding thereto (i) ascorbic acid or an ester or salt thereof, and (ii) a phosphorylated mono- or di-fatty acyl glyceride or a salt thereof, and optionally a tocopherol or tocotrienol antioxidant, and a method of preparing stable pharmaceutical, nutritional or veterinary compositions.
Patent AU-660093-B2 (AU)
Title: Recombinant feline herpesvirus vaccine
Inventor: WILLEMSE MARTHA JACOBA
IPC: A61K39/295
Filed: 1993-06-24
Granted: 1995-06-08
Abstract: The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome. The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and induces an adequate immune response in an inoculated host against both FHV and the feline pathogen.
Patent AU-764356-B2 (AU)
Title: Resin system
Inventor: VOHWINKEL FRIEDRICH
IPC: C08G59/42
Filed: 1999-06-25
Granted: 2003-08-14
Abstract: The resin system comprises at least two components which can be stored separately and crosslinked with one another at room temperature, preferably without curing accelerators. The first component comprises at least one compound of the formula (I)where A is an unsubstituted or substituted aromatic radical.The second component comprises at least one cyclic anhydride of an organic acid. However, the compound of the formula (I) here is not a compound of the formula (II)where m=1 or 2,if the cyclic anhydride is a compound of the formula (III)where A is a carbonyl radical, or has the formulawhere each radical Ro is a hydrogen atom or halogen atom, a hydroxyl radical or a C1-C5-alkyl radical or an alkoxy radical, or a C1-C5-alkyl-substituted oxycarbonyl radical, and R' and R'', independently of one another, are hydrogen atoms or halogen atoms, C1-C5-alkyl groups, nitro groups, carboxyl groups, sulfonyl groups or amino groups.
Patent AU-750016-B2 (AU)
Title: Release sheet for use with multicomponent reactive urethane systems and method of manufacture
Inventor: GLASSOCK JUDITH I
IPC: B29C33/68
Filed: 1999-06-02
Granted: 2002-07-11
Abstract: A flexible composite release sheet providing a replicative surface with a desired surface effect and a method of manufacturing such a release sheet is disclosed. The release sheet is suitable for use in multicomponent reactive urethane casting systems. The invention further provides flexible composite release sheets having a first acrylic functional coating layer containing the desired surface effect and a second silicone release coating layer overlying the acrylic functional coating layer.